Presentation Materials

Apr 12, 2018: Information Meeting on TECENTRIQ®

1. TECENTRIQ® Intravenous Infusion 1200mg Product Overview: Mikio Sakai, TECENTRIQ® Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
2. The Anti-PD-L1 Antibody Tecentriq® Mode of Action and Future Outlook: Hiroyoshi Nishikawa, M.D., Ph.D.
Department of Immunology, Nagoya University Graduate School of Medicine
Exploratory Oncology Research & Clinical Trial Center, Research Institute, National Cancer Center
3. Treatment Overview of Non-Small Cell Lung Cancer and Clinical Trials for Tecentriq®: Yuichiro Ohe, M.D.
Deputy Director, Chief,
Division of Thoracic Oncology
National Cancer Center Hospital, Japan

Information Meeting on TECENTRIQ® [9.5MB]
Webcasts

2018

Feb 02	Investor Conference on FY 2017.12 Financial Results Investor Conference on FY 2017.12 Financial Results [1.5MB] Webcasts

2017

Oct 25	3Q Results (Jan - Sep 2017) Conference Call FY2017 3Q Consolidated Financial Overview [555KB] Webcasts
Jul 28	Investor Conference on FY2017 2Q Financial Results FY2017 2Q Consolidated Financial Overview [1015KB] Webcasts
Jul 11	R&D Conference Call (ISTH 2017) R&D Conference Call (ISTH 2017) [445KB] Webcasts
Jun 29	R&D Conference Call R&D Conference Call [1.1MB] Webcasts
Apr 25	1Q Results (Jan-Mar 2017) Conference Call FY2017 1Q Consolidated Financial Overview [484KB] Webcasts
Feb 02	Information Meeting on FY 2016.12 Financial Results Information Meeting on FY 2016.12 Financial Results [895KB] Webcasts

2016

Dec 14	CEO Meeting CEO Meeting [1.2MB] Webcasts
Oct 25	3Q Results (Jan - Sep 2016) Conference Call FY2016 3Q Consolidated Financial Overview [457KB] Webcasts
Jul 22	Information Meeting on FY2016 2Q Financial Results FY2016 2Q Consolidated Financial Overview [1MB] Webcasts
Jul 04	R&D Conference Call R&D Conference Call [617KB] Webcasts
Apr 22	1Q Results (Jan-Mar 2016) Conference Call FY2016 1Q Consolidated Financial Overview [381KB] Webcasts
Apr 05	Information Meeting on Bonviva® Information Meeting on Bonviva® [3MB] Webcasts
Jan 29	Information Meeting on FY 2015.12 Financial Results Information Meeting on FY 2015.12 Financial Results [1.8MB] Webcasts

2015

Oct 22	3Q Results (Jan 15 - Sep 15) Conference Call FY2015 3Q Consolidated Financial Overview [414KB] Webcasts
Jul 24	Information Meeting on FY 2015.12 2Q Financial Results FY2015 2Q Consolidated Financial Overview [610KB] Webcasts
Apr 22	1Q Results (Jan 15 - Mar 15) Conference Call FY2015 1Q Consolidated Financial Overview [333KB] Webcasts
Apr 02	Information Meeting on ZELBORAF® Information Meeting on ZELBORAF® [2.1MB] Webcasts
Jan 29	Information Meeting on FY 2014.12 Financial Results Information Meeting on FY 2014.12 Financial Results [745KB] Webcasts

2014

Dec 16	Information Meeting on Research & Development Webcasts Information Meeting on Research & Development [1.1MB]
Oct 24	3Q Results (Jan 14 - Sep 14) Conference Call FY2014 3Q Consolidated Financial Overview [474KB] Webcasts
Aug 21	Information Meeting on ALECENSA® Information Meeting on ALECENSA® [2.6MB] Webcasts
Jul 25	Information Meeting on FY 2014.12 2Q Financial Results FY2014 2Q Consolidated Financial Overview [705KB] Webcasts
Apr 24	1Q Results (Jan 14 - Mar 14) Conference Call FY2014 1Q Consolidated Financial Overview [439KB] Webcasts
Jan 31	Information Meeting on FY 2013.12 Financial Results Information Meeting on FY 2014.12 Financial Results [1.5MB] Webcasts

Earlier Presentation Materials

TSE Code:4519

Share Graph

IFRS References

ESG References

Supplementary Materials

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Chugai Pharmaceutical Co., Ltd. takes great care over the information presented on this website, but it does not guarantee its accuracy, completeness, usefulness, etc. Furthermore, Chugai Pharmaceutical Co., Ltd. will not be responsible for any damages resulting from the use of this website or the information presented on this website. For further details, please read the following "Terms and Conditions of Website Use."